Flow Cytometry Companies Strategic Expansion Initiatives, Revenue Diversification, Strategic Joint Ventures, Licensing and Monetization, Peer Comparison Analysis, Leadership and Governance

Flow Cytometry Manufacturers and Market Growth

The flow cytometry market size was estimated at US$ 4.35 billion in 2023 and is projected to grow to US$ 9.16 billion by 2034, rising at a compound annual growth rate (CAGR) of 7% from 2024 to 2034.

Top Companies in the Flow Cytometry Market

• Agilent Technologies
• Beckman Coulter Lifesciences
• Becton, Dickinson and Company
• BioAffinity Technologies
• Biotium
• Bio-Rad Laboratories
• Cytek Biosciences
• Danaher Corporation
• LabCorp Drug Development
• Luminex Corporation
• Sony Corporation
• Sysmex Corporation
• Thermo Fisher Scientific

Latest Announcements by Industry Leaders

Dr. Bill Hanlon, CSO, LabCorp Drug Development, said that flow cytometry has enormous unrealized potential as a companion diagnostic in cancer and other therapeutic fields and is a reliable and effective technique for examining cells to better understand the illness. In order to increase acceptance and eventually bring cutting-edge novel companion diagnostics to market to assist in identifying patients who might benefit most from suitable therapies, he also stated that their strategic partnership with BD, a pioneer and worldwide leader in flow cytometry, is an exciting move.

Recent Developments in the Flow Cytometry Market

• In October 2024, bioAffinity Technologies developed a novel CyPath Lung non-invasive test for the early detection of lung cancer that uses sputum, a unique sample type that is not typically used in clinical flow cytometry assays.
• In May 2024, Bio-Rad Laboratories announced the launch of three new StarBright Red Dyes and an expansion of its StarBright Violet Dye Series to expand translational and immunological research capabilities by providing flexibility in flow cytometry.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com